Status:
COMPLETED
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
Lead Sponsor:
Hacettepe University
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Cystic Fibrosis (CF) affects more than one body system, mainly respiratory and digestive.The quality of life of individuals with CF is adversely affected by the increasing treatment burden in addition...
Detailed Description
Cystic Fibrosis (CF) is a chronic, progressive, and autosomal recessive disease that shortens life expectancy caused by mutations in the Cystic Fibrosis Transmembrane Regulator (CFTR ) gene. It affect...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Individuals over the age of 18 with a diagnosis of CF
- Volunteering to participate in research
- Exclusion Criteria
- Not volunteering to participate in the research
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06128499
Start Date
January 1 2024
End Date
April 30 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Altındağ, Turkey (Türkiye), 06230